Alberto Bossi, MD, underscores brachytherapy's dual advantages for prostate cancer patients. By enhancing local disease control and offering a patient-friendly side effect profile—especially with HDR brachytherapy—brachytherapy emerges as a pivotal treatment choice. His insights illuminate the transformative potential of this approach in prostate cancer care.
Discover more on https://www.elekta.com/products/brachytherapy/prostate/radiation-oncologists/?
